Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aptamers as tools for target validation.

Michael Blank1, Michael Blind

  • 1NascaCell IP GmbH, München, Germany.

Current Opinion in Chemical Biology
|July 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Function through shape: An overview of DNA G-quadruplexes in transcriptional regulation.

Current opinion in chemical biology·2026
Same journal

Advances in tools and technologies for multiplexed bioluminescence imaging.

Current opinion in chemical biology·2026
Same journal

High-resolution molecular mapping by expansion-coupled label-free and multimodal imaging.

Current opinion in chemical biology·2026
Same journal

Recent advances in glycoconjugate-based therapeutics.

Current opinion in chemical biology·2026
Same journal

Towards better red emitters for bioimaging: Innovations in rhodamine and cyanine chemistry.

Current opinion in chemical biology·2026
Same journal

Chemigenetic fluorescent biosensors in biological imaging - New trends and advances.

Current opinion in chemical biology·2026
See all related articles

Synthetic nucleic acid aptamers offer high specificity and affinity for protein targets, significantly advancing drug development. This technology enables rapid identification of aptamers for high-throughput analysis and validation of drug targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Aptamers are synthetic nucleic acid ligands that bind to specific protein targets with high affinity.
  • They function as potent inhibitors of protein activity, crucial for biological research and therapeutic development.

Purpose of the Study:

  • To highlight the utility of aptamer technology in target validation and drug development.
  • To emphasize the advancements in rapid, automated aptamer identification for high-throughput screening.
  • To discuss the complementary role of aptamers alongside genetic methods for proteomic analysis.

Main Methods:

  • Development of aptamer technology for high-throughput screening.
  • Application of aptamers for inhibiting protein function in vitro and in vivo.

Related Experiment Videos

  • Extension of aptamer technology for drug development and lead identification.
  • Main Results:

    • Aptamers demonstrate high specificity and affinity for protein targets.
    • Automated platforms enable rapid identification of aptamers for diverse targets.
    • Aptamers effectively inhibit protein function in cellular and animal models.
    • Aptamer technology complements genetic approaches, providing proteomic-level insights.

    Conclusions:

    • Aptamer technology is a powerful tool for target validation and drug discovery due to its specificity, affinity, and rapid identification methods.
    • Its ability to inhibit protein function and complement genetic techniques makes it valuable for advancing pharmaceutical research.
    • Recent extensions of aptamer technology show promise for developing novel aptamer-based therapeutics and identifying small molecule drug leads.